Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis M Tebit

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Plos One|August 26, 2024
Immunologic, virologic and drug resistance outcomes in an HIV-infected prospective cohort on treatment in South AfricaBixa Ogola, Nontokozo D Matume, Denis M Tebit, et al.
AIDS Research and Human Retroviruses|June 10, 2021
Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South AfricaBixa Ogola, Nontokozo D Matume, Lufuno G Mavhandu-Ramarumo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 18, 2018
Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South AfricaNontokozo D Matume, Denis M Tebit, Laurie R Gray, et al.
Medchemcomm|July 26, 2016
Effect of intercalator and Lewis acid-base branched peptide complex formation: boosting affinity towards HIV-1 RRE RNAJessica E Wynn, Wenyu Zhang, Denis M Tebit, et al.
Bioorganic & Medicinal Chemistry|April 20, 2016
Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNAJessica E Wynn, Wenyu Zhang, Denis M Tebit, et al.
AIDS Research and Therapy|October 6, 2015
Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usageImmaculate L Nankya, Denis M Tebit, Awet Abraha, et al.
AIDS Research and Human Retroviruses|February 11, 2016
HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral DrugsDenis M Tebit, Hamish Patel, Annette Ratcliff, et al.
BMC Medical Genetics|January 21, 2019
Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South AfricaNontokozo D Matume, Denis M Tebit, Laurie R Gray, et al.
Virology|August 24, 2004
Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivativesDenis M Tebit, Léopold Zekeng, Lazare Kaptué, et al.
Journal of Virology|July 16, 2010
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitorsDenis M Tebit, Michael Lobritz, Matthew Lalonde, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Plos One|August 26, 2024
Immunologic, virologic and drug resistance outcomes in an HIV-infected prospective cohort on treatment in South AfricaBixa Ogola, Nontokozo D Matume, Denis M Tebit, et al.
AIDS Research and Human Retroviruses|June 10, 2021
Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South AfricaBixa Ogola, Nontokozo D Matume, Lufuno G Mavhandu-Ramarumo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 18, 2018
Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South AfricaNontokozo D Matume, Denis M Tebit, Laurie R Gray, et al.
Medchemcomm|July 26, 2016
Effect of intercalator and Lewis acid-base branched peptide complex formation: boosting affinity towards HIV-1 RRE RNAJessica E Wynn, Wenyu Zhang, Denis M Tebit, et al.
Bioorganic & Medicinal Chemistry|April 20, 2016
Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNAJessica E Wynn, Wenyu Zhang, Denis M Tebit, et al.
AIDS Research and Therapy|October 6, 2015
Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usageImmaculate L Nankya, Denis M Tebit, Awet Abraha, et al.
AIDS Research and Human Retroviruses|February 11, 2016
HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral DrugsDenis M Tebit, Hamish Patel, Annette Ratcliff, et al.
BMC Medical Genetics|January 21, 2019
Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South AfricaNontokozo D Matume, Denis M Tebit, Laurie R Gray, et al.
Virology|August 24, 2004
Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivativesDenis M Tebit, Léopold Zekeng, Lazare Kaptué, et al.
Journal of Virology|July 16, 2010
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitorsDenis M Tebit, Michael Lobritz, Matthew Lalonde, et al.
Pageof 4